Clinical Trial Update: A Phase I/II Study of LM-2417 in Subjects With Advanced Solid Tumours [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II study evaluating LM-2417 in adults with advanced solid tumors, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• LM-2417

Snippet

Sponsor: LaNova Medicines Limited | Conditions: Advanced Solid Tumor | Phase 1, Phase 2 | Status: RECRUITING